Javascript must be enabled to continue!
HPV prevalence and Detection Sensitivity in Vaginal Intraepithelial Neoplasia: a hospital-based study
View through CrossRef
Vaginal intraepithelial neoplasia (VaIN) always diagnosed through
coloscopy accidentally when the cervical cancer screening was abnormal.
A precise estimate of the detection rate of cervical cancer screening
for VaIN is limited. This study to investigated the characteristics and
screening history of VaIN, and compared the sensitivity of cytology and
human papillomavirus tests on the cervix against vaginal and cervical
high-grade squamous intraepithelial lesion (HSIL) or cancer. A total of
1200 patients with definitive histopathologic diagnoses of VaIN were
included in this study. Among them, 22.5% were diagnosed with VaIN2+,
and 50.4% were concomitant with cervical lesions. The median age of
VaIN2+ patients was 41.5 years old , while VaIN1 reported a median age
of 53 years old , p<0.001. This study reported that VaIN was
significantly and positively correlated with cervical lesions (r=0.387).
The high-risk human papillomavirus (hr-HPV) detection rate was 88.5%
(883/998) in VaIN and 95.4% in VaIN2+. HPV 16 was the most prevalent
HPV type in VaIN2+, which accounted for 54.5%, followed by HPV58
(17.0%), HPV52 (14.8%), HPV51 (11.4%), and HPV18 (10.2%). The
sensitivity of hr-HPV and cytology tests on the cervix for detecting
VaIN2+ was 95.0% and 84.9%, respectively. Both tests were not
significantly different from detecting CIN2+. When the cervical cancer
screening is abnormal and referring to colposcopy, acetic acid and
Lugol’s iodine need to cover the whole vaginal mucosa as well as the
fornix, attention need to be paid for the abnormal images of vagina in
order to find VaIN.
Title: HPV prevalence and Detection Sensitivity in Vaginal Intraepithelial Neoplasia: a hospital-based study
Description:
Vaginal intraepithelial neoplasia (VaIN) always diagnosed through
coloscopy accidentally when the cervical cancer screening was abnormal.
A precise estimate of the detection rate of cervical cancer screening
for VaIN is limited.
This study to investigated the characteristics and
screening history of VaIN, and compared the sensitivity of cytology and
human papillomavirus tests on the cervix against vaginal and cervical
high-grade squamous intraepithelial lesion (HSIL) or cancer.
A total of
1200 patients with definitive histopathologic diagnoses of VaIN were
included in this study.
Among them, 22.
5% were diagnosed with VaIN2+,
and 50.
4% were concomitant with cervical lesions.
The median age of
VaIN2+ patients was 41.
5 years old , while VaIN1 reported a median age
of 53 years old , p<0.
001.
This study reported that VaIN was
significantly and positively correlated with cervical lesions (r=0.
387).
The high-risk human papillomavirus (hr-HPV) detection rate was 88.
5%
(883/998) in VaIN and 95.
4% in VaIN2+.
HPV 16 was the most prevalent
HPV type in VaIN2+, which accounted for 54.
5%, followed by HPV58
(17.
0%), HPV52 (14.
8%), HPV51 (11.
4%), and HPV18 (10.
2%).
The
sensitivity of hr-HPV and cytology tests on the cervix for detecting
VaIN2+ was 95.
0% and 84.
9%, respectively.
Both tests were not
significantly different from detecting CIN2+.
When the cervical cancer
screening is abnormal and referring to colposcopy, acetic acid and
Lugol’s iodine need to cover the whole vaginal mucosa as well as the
fornix, attention need to be paid for the abnormal images of vagina in
order to find VaIN.
Related Results
(O-15) HPV infection and genotype distribution among male patients attending a sexual health clinic in Lima from 2024 to 2025
(O-15) HPV infection and genotype distribution among male patients attending a sexual health clinic in Lima from 2024 to 2025
Abstract
Introduction
Human papillomavirus (HPV) is a serious global public health problem due to its high prevalence and...
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17-year-old
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17-year-old
AbstractbackgroundHuman papillomavirus (HPV) is one of the most prevalent sexually transmitted viruses in the world, and is associated with many medical conditions cervical cancer ...
High rate of non-vaccine-targeted high-risk HPV genotypes in Ethiopia: Its implication in future vaccine selection
High rate of non-vaccine-targeted high-risk HPV genotypes in Ethiopia: Its implication in future vaccine selection
Abstract
Since the distribution of high-risk HPV genotypes varies across countries, genotype-based vaccination is widely recommended to control the burden of cervical cance...
Prevalence of HPV in a Peruvian Healthcare Network: A Descriptive Cross-Sectional Study
Prevalence of HPV in a Peruvian Healthcare Network: A Descriptive Cross-Sectional Study
Introduction
Human papillomavirus (HPV) infection is a common sexually transmitted infection often associated with cancer development. This study aimed to estim...
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
Trajectories of and spatial variations in HPV vaccine discussions on Weibo, 2018-2023: a deep learning analysis
SummaryResearch in contextEvidence before this studyWe first searched PubMed for articles published until November 2023 with the keywords “(“HPV”) AND (“Vaccine” or “Vaccination”) ...
Cervical Cancer: What Vaccine in Senegal?
Cervical Cancer: What Vaccine in Senegal?
Introduction: Cervical cancer (CC) is first cancer in terms of frequency and mortality among women in Senegal. This is a public health problem hence the urgency of preventive measu...
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
Abstract
The World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention st...
Abstract 2180: Immune, keratinocyte, and fibroblast expression signatures distinguish HNSCC samples by HPV status
Abstract 2180: Immune, keratinocyte, and fibroblast expression signatures distinguish HNSCC samples by HPV status
Abstract
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer in the world. HPV-positive HNSCC is considered a disti...

